ニュース

Nikkei Bio Article: Perseus Proteomics, development of an anti-TfR antibody for ANKL submitted for regulatory approval with results from phase 1/2 trial

Nikkei Bio article in JP:

https://bio.nikkeibp.co.jp/atc...